tirzepatide once a month Monthly GLP-1 for Weight Maintenance What to Expect on Tirzepatide:

4 The FDA approved the Wegovy pill for weight loss on December 22, 2025 and its expected to be available to patients in early January 2026

In people with type 2 diabetes who also use insulin or insulin-stimulating drugs, such as sulfonylureas, the risk of low blood sugar, also called hypoglycemia, may be increased, so the doses of those medicines may need to be lowered

This washout period helps normalize nutrient absorption, restore regular appetite signaling, and re-establish hormonal patterns that support ovulation

For combined therapy it lists the risk as potentially additive and requiring caution

signs license agreement for Hansoh Pharma GLP-1 receptor agonist Dec